AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (316.2 KB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Research Highlight | Open Access

On demand CRISPR-mediated RNA N6-methyladenosine editing

Ying XuFu-Sen Liang( )
Department of Chemistry, Case Western Reserve University, Cleveland, OH 44106, USA

Peer review under responsibility of Chongqing Medical University.

Show Author Information

References

1

Boccaletto P, Stefaniak F, Ray A, et al. MODOMICS: a database of RNA modification pathways. 2021 update. Nucleic Acids Res. 2022;50(D1):D231-D235.

2

Schaefer MR. The regulation of RNA modification systems: the next frontier in epitranscriptomics? Genes. 2021;12(3):345.

3

Zhao BS, Roundtree IA, He C. Post-transcriptional gene regulation by mRNA modifications. Nat Rev Mol Cell Biol. 2017;18(1):31-42.

4

Lo N, Xu X, Soares F, He HH. The basis and promise of programmable RNA editing and modification. Front Genet. 2022;13:834413.

5

Shi H, Xu Y, Tian N, Yang M, Liang FS. Inducible and reversible RNA N6-methyladenosine editing. Nat Commun. 2022;13:1958.

Genes & Diseases
Pages 1389-1390
Cite this article:
Xu Y, Liang F-S. On demand CRISPR-mediated RNA N6-methyladenosine editing. Genes & Diseases, 2022, 9(6): 1389-1390. https://doi.org/10.1016/j.gendis.2022.05.019

297

Views

8

Downloads

2

Crossref

2

Web of Science

2

Scopus

0

CSCD

Altmetrics

Received: 25 May 2022
Accepted: 25 May 2022
Published: 03 June 2022
© 2022, Chongqing Medical University.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Return